Case by Case | Court of Appeal rejects Guardant Health’s preliminary injunction application due to unreasonable delay

In a decision dated 2 July 2026, the Court of Appeal (CoA) provided guidance on the steps a patentee should take to comply with the urgency requirement in the preliminary injunction proceedings brought by Guardant Health (Guardant) against SOPHiA Genetics’ (SOPHiA) liquid biopsy test. Bristows represented SOPHiA in these proceedings.Florence Plisner explains more in this episode.If you have any feedback, questions, or comments, please email us at [email protected] all the episodes as we release them here. Follow us on LinkedIn.